GL1X · GenesisL1 explorer

Research workbench

Novel covalent active site thrombin inhibitors

Analyse Novel covalent active site thrombin inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1QHR
Type
protein
Length
305 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha thrombin; Hirugen
EC
3.4.21.5
UniProt
P00734, P28501
Ligands
157
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 3 distinct chains · 16% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha thrombin (EC 3.4.21.5)protein3628% helix, 0% strandP00734
BAlpha thrombin (EC 3.4.21.5)protein25914% helix, 35% strandP00734
IHirugenprotein1030% helix, 0% strandP28501

Ligands and binding sites

  • 157 · 6-(2-hydroxy-cyclopentyl)-7-oxo-heptanamidine · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12220.570.7931157
2900.400.7715empty
3550.310.7611empty

Interfaces

2 interfaces between chains.

  • A–B · 1219 Ų buried · 27 hydrogen bonds · protein-protein
  • B–I · 624 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 covalent, 1 modified (disulfide, covalent ligand, sulfation).

Compared structures

  • 1QHR · Novel covalent active site thrombin inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.